BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2095238)

  • 21. Thyroglobulin before ablative radioiodine therapy.
    Grünwald F; Menzel C; Biersack HJ
    Eur J Nucl Med; 2000 Apr; 27(4):461. PubMed ID: 10805121
    [No Abstract]   [Full Text] [Related]  

  • 22. Lessons from a review of thyroglobulin assays in the management of thyroid cancer.
    Wong J; Lu Z; Doery J; Fuller P
    Intern Med J; 2008 Jun; 38(6):441-4. PubMed ID: 18613899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of tumor markers in monitoring thyroid carcinoma].
    Gorgone S; Lazzara S; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
    Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory services for thyroglobulin and implications for monitoring of differentiated thyroid cancer.
    Clark PM
    J Clin Pathol; 2009 May; 62(5):402-6. PubMed ID: 19398593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Humoral markers in thyroid carcinoma].
    Pinchera A; Pacini F; Martino E; Anelli S
    Minerva Med; 1986 Nov; 77(44):2089-91. PubMed ID: 3785723
    [No Abstract]   [Full Text] [Related]  

  • 26. Humoral markers for thyroid carcinoma.
    Pacini F; Martino E; Bambini G; Aghini-Lombardi F; Taddei D; Lari R; Pinchera A; Baschieri L
    Cancer Detect Prev; 1985; 8(1-2):17-22. PubMed ID: 4064037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The significance of thyroglobulin determination in the follow-up of patients with papillary or follicular thyroid carcinoma].
    Hennemann G; Hennemann IP; Docter R; Krenning EP
    Ned Tijdschr Geneeskd; 1989 Mar; 133(10):491-3. PubMed ID: 2651932
    [No Abstract]   [Full Text] [Related]  

  • 28. [Radioimmunological methods in the diagnosis of metastases of thyroid cancer].
    Lozinskaia IN; Vikman IaE
    Med Radiol (Mosk); 1987 Jun; 32(6):6-9. PubMed ID: 3600228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The clinical usefulness of tumor markers in thyroid neoplastic pathology. Our experience].
    Gerardi G; De Angelis P
    Minerva Med; 1994 May; 85(5):237-40. PubMed ID: 8028752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case 53: adenolipoma of the thyroid gland.
    Borges A; Catarino A
    Radiology; 2002 Dec; 225(3):746-50. PubMed ID: 12461256
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diagnostic problems in thyroid cancer].
    Di Filippo B; Angelillo R; Angelillo M; Carrillo F
    Minerva Chir; 1982 Mar; 37(5):485-6. PubMed ID: 7088355
    [No Abstract]   [Full Text] [Related]  

  • 32. Laboratory diagnosis of thyroid tumors.
    DeGroot LJ
    Ann Clin Lab Sci; 1983; 13(2):77-82. PubMed ID: 6305255
    [No Abstract]   [Full Text] [Related]  

  • 33. [Tumor markers for thyroid malignant disease].
    Tamura K
    Nihon Rinsho; 2011 Mar; 69 Suppl 2():298-303. PubMed ID: 21830558
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tumor markers for endocrine neoplasms].
    Okamoto T
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):561-5. PubMed ID: 11329795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid: diagnostic techniques.
    Kenady DE; Schwartz RW
    Curr Opin Oncol; 1990 Feb; 2(1):87-94. PubMed ID: 2095238
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnostic imaging and function tests in thyroid neoplasm].
    Yojin K
    Nihon Jibiinkoka Gakkai Kaiho; 1997 Nov; 100(11):1408-11. PubMed ID: 9480340
    [No Abstract]   [Full Text] [Related]  

  • 37. [Multimodal imaging in medullary thyroid carcinomas].
    Müssig K; Bares R; Horger M
    Rofo; 2010 Nov; 182(11):925-8. PubMed ID: 21031322
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.